首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies
【24h】

Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies

机译:超高效液相色谱串联质谱法测定佐剂性关节炎大鼠血浆中gen子苷的含量及其在口服生物利用度和血浆蛋白结合能力研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

A specific, sensitive and high throughput ultra-high performance liquid chromatography-electrospray ionization tandem mass spectrometric method (UHPLC-ESI-MS/MS) was established and validated to assay geniposide (GE), a promising anti-inflammatory drug, in adjuvant arthritis rat plasma: application to pharmacokinetic and oral bioavailability studies and plasma protein binding ability. Plasma samples were processed by de-proteinised with ice-cold methanol and separated on an ACQUITY UPLC (TM) HSS C18 column (100 mm x 2.1 mm i.d., 1.8 mu m particle size) at a gradient flow rate of 0.2 mL/min using acetonitrile-0.1% formic acid in water as mobile phase, and the total run time was 9 min. Mass detection was performed in selected reaction monitoring (SRM) mode with negative electro-spray ionization includes the addition of paeoniflorin (Pae) as an internal standard (IS). The mass transition ion-pair was followed as m/z 387.4 -> 122.4 for GE and m/z 479.4 -> 449.0 for IS. The calibration curves were linear over the concentration range of 2-50,000 ng/mL with lower limit of quantification of 2 ng/mL. The intra-day and inter-day precisions (RSD, %) of the assay were less than 8.4%, and the accuracy was within 6.4% in terms of relative error (RE). Extraction recovery, matrix effect and stability were satisfactory in adjuvant arthritis rat plasma. The UHPLC-ESI-MS/MS method was successfully applied to a pharmacokinetic study of GE after oral administration of depurated GE at 33, 66, 132 mg/kg and intravenous injection at 33, 66, 132 mg/kg in adjuvant arthritis (AA) rats. In addition, it was found that GE has rapid absorption and elimination, low absolute bioavailability, high plasma protein binding ability in AA rats after oral administration within the tested dosage range. It suggested that GE showed slow distribution into the intra- and extracellular space, and the binding rate was not proportionally dependent on plasma concentration of GE when the concentration of GE was below 5.0 mu z/mL. (C) 2015 Elsevier B.V. All rights reserved.
机译:建立了一种特异性,灵敏,高通量的超高效液相色谱-电喷雾串联质谱法(UHPLC-ESI-MS / MS),并已验证该药可用于测定佐剂关节炎中的一种有希望的消炎药子苷(GE)大鼠血浆:应用于药代动力学和口服生物利用度研究以及血浆蛋白结合能力。血浆样品通过用冰冷的甲醇脱蛋白处理,并在ACQUITY UPLC(TM)HSS C18色谱柱(100 mm x 2.1 mm内径,粒径为1.8μm)上分离,流速为0.2 mL / min。乙腈-0.1%甲酸水溶液作为流动相,总运行时间为9分钟。在选定的反应监测(SRM)模式下进行质量检测,并进行负电喷雾电离,包括添加pa药苷(Pae)作为内标(IS)。质量转变离子对的跟踪结果为:GE的m / z 387.4-> 122.4,IS的m / z 479.4-> 449.0。校准曲线在2-50,000 ng / mL的浓度范围内呈线性,定量下限为2 ng / mL。该方法的日内和日间精度(RSD,%)小于8.4%,相对误差(RE)的准确性在6.4%以内。佐剂关节炎大鼠血浆中的提取回收率,基质作用和稳定性均令人满意。在佐剂性关节炎(AA)中口服33,66,132 mg / kg的纯净GE和33,66,132 mg / kg的静脉注射后,UHPLC-ESI-MS / MS方法已成功应用于GE的药代动力学研究)大鼠。另外,发现在测试剂量范围内,口服给药后AA大鼠中GE具有快速吸收和消除,低绝对生物利用度,高血浆蛋白结合能力。提示当GE的浓度低于5.0μz/ mL时,GE在细胞内和细胞外的空间分布缓慢,结合速率与GE的血浆浓度不成比例。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号